Kerstin A. David
Hoofd Techniek/Wetenschap/O&O bij Indivumed GmbH
Profiel
Kerstin A.
David is currently the Chief Scientific Officer at Indivumed GmbH.
Prior to this, she worked as an Assistant Professor at the University of Hamburg and the Cancer Research Center of Hawaii.
She holds a doctorate degree from the University of Hamburg.
Actieve functies van Kerstin A. David
| Bedrijven | Functie | Begin |
|---|---|---|
Indivumed GmbH
 Indivumed GmbH Data Processing ServicesTechnology Services Indivumed GmbH engages in the research and development of medical treatment for cancer patients. The firm develops an integrated analytical platform, which links sample sets from cancer patients such as tissue types, serum, plasma, and urine with a web-accessible database. It offers treatment for the people suffering from GI-tract such as colorectal, gastric, pancreatic, breast, and lung cancer. The company was founded by Hartmut Juhl, Carsten Zornig and Peter Layer in April 2002 and is headquartered in Hamburg, Germany. | Hoofd Techniek/Wetenschap/O&O | 01-01-2002 |
Eerdere bekende functies van Kerstin A. David
| Bedrijven | Functie | Einde |
|---|---|---|
| Cancer Research Center of Hawaii | Corporate Officer/Principal | - |
| University of Hamburg | Corporate Officer/Principal | - |
Opleiding van Kerstin A. David
| University of Hamburg | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Indivumed GmbH
Indivumed GmbH Data Processing ServicesTechnology Services Indivumed GmbH engages in the research and development of medical treatment for cancer patients. The firm develops an integrated analytical platform, which links sample sets from cancer patients such as tissue types, serum, plasma, and urine with a web-accessible database. It offers treatment for the people suffering from GI-tract such as colorectal, gastric, pancreatic, breast, and lung cancer. The company was founded by Hartmut Juhl, Carsten Zornig and Peter Layer in April 2002 and is headquartered in Hamburg, Germany. | Technology Services |
| Cancer Research Center of Hawaii |
